Kids v Cancer

What Kids v Cancer does

Kids v Cancer is a Washington, DC-based 501(c)(3) nonprofit (EIN 27-1427784) founded in 2012 by Nancy Goodman that functions as a pediatric cancer think tank and advocacy organization. It serves three primary stakeholder groups: pediatric cancer patients and families who need navigation support, federal policymakers who set research funding and regulatory frameworks, and the FDA on pediatric oncology drug development policy. The organization's core products are a portfolio of patient-support and policy-advocacy programs, including the Compassionate Use Navigator (helping families access experimental therapies), Trial Eligibility resources, Post Mortem Tissue Donation, the annual "Climb the Hill" Capitol Hill advocacy event, Voices of Kids, and We Remember. Its central policy product is the Mikaela Naylon Give Kids a Chance Act, signed into law on February 3, 2026, which granted FDA new authority to require combination drug trials for pediatric cancers, authorized FDA to penalize non-compliant sponsors, and reauthorized the Rare Pediatric Disease Priority Review Voucher Program through fiscal year 2029.

Underlying technology is light by commercial standards: a Squarespace-hosted website, Constant Contact email integration, a GiveLively donation flow, and a single prototype AI tool (a "DRAFT" genomic-alteration drug lookup built on a Claude.ai public artifact). The organization's strategic assets are reputational and political rather than technical, including direct authorship of landmark pediatric oncology legislation, recurring national media coverage, and endorsements from AACR, the Drucker Foundation, Fast Company, and Massachusetts General Hospital. Its business model is donation-funded; all programs are free to beneficiaries, and revenue is not publicly disclosed. Partnership with Mystic Force Foundation extends its Capitol Hill reach, and FY2027 appropriations requests of $35 million (STAR Act) and $100 million (Childhood Cancer Data Initiative) indicate ongoing efforts to scale federal funding influence rather than commercial revenue.

Name

Kids v Cancer

Legal name

Kids V Cancer

Website

https://givekidsachanceact.org

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

Kids v Cancer is a Washington, DC-based 501(c)(3) nonprofit think tank founded in 2012 that advocates for pediatric cancer patients through federal legislation, FDA policy work, and direct family-support programs such as the Compassionate Use Navigator, Trial Eligibility, and Post Mortem Tissue Donation.

Ownership category

akta.pro rank

Product category

Pediatric Cancer Advocacy

NAICS

Voluntary Health Organizations (813212)

SIC

Services-Social Services (8300)

akta.pro primary industry

Funding, Reimbursement & Vaccines-for-Children (VFC)/Public Purchase Programs (HLAJAHAK)

Keywords

• Pediatric cancer advocacy
• Childhood cancer research
• Legislative policy advocacy
• Patient support programs
• Clinical trial navigation

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Donations: The organization accepts donations via check, donor-advised fund (DAF), credit card, and Apple Pay through their website, supporting their advocacy and program operations.

Go-to-market motion3 records

Distribution channels1 record

Marketing channels3 records

Core offering

Kids v Cancer is a nonprofit pediatric cancer think tank that operates free patient support programs, including a Compassionate Use Navigator, a Post Mortem Tissue Donation program, and Trial Eligibility resources, while pursuing federal legislative advocacy on childhood cancer research funding and drug development policy. The organization runs an annual Climb the Hill Capitol Hill advocacy event and provides an AI-powered draft tool to help families identify potential drug therapies based on a child's genomic alterations.

Product overview

Kids v Cancer is a non-profit advocacy organization focused on changing the landscape of pediatric cancer through legislative advocacy and patient support programs. The organization operates a portfolio of interconnected programs including the Compassionate Use Navigator (helping families access experimental treatments), Trial Eligibility, Post Mortem Tissue Donation, and advocacy initiatives like Climb the Hill and Voices of Kids. The core policy work centers on the Mikaela Naylon Give Kids a Chance Act and Priority Review Voucher advocacy. The organization also provides a DRAFT AI tool to help families identify potential therapies based on genomic alterations. These programs work together to advance federal funding, legislative changes, and direct support for children with cancer and their families.

Differentiator

Problem solved

Functional benefit

Brands

• Mikaela Naylon Give Kids a Chance Act: Key legislative initiative advocating for pediatric cancer research and drug development policies
• Compassionate Use Navigator
• Climb the Hill

Products and services

• Compassionate Use Navigator A program that helps families of seriously ill children navigate the compassionate use process for accessing experimental cancer treatments. Free resource available through the Kids v Cancer website for pediatric cancer patients and their families.
• Post Mortem Tissue Donation Program A program facilitating post-mortem tissue donation from deceased pediatric cancer patients to advance cancer research. Free resource available through the Kids v Cancer website for bereaved families.
• Trial Eligibility Program A program that helps families understand and navigate clinical trial eligibility requirements for pediatric cancer treatments. Free resource available through the Kids v Cancer website for patients and families.
• Climb the Hill An annual advocacy event where pediatric cancer advocates, families, and survivors meet with Congressional lawmakers on Capitol Hill to push for childhood cancer research funding and legislation. Held for 13 consecutive years.
• Voices of Kids A program amplifying the voices and stories of children affected by cancer to support advocacy efforts.
• We Remember A memorial program honoring children who have passed away from cancer.
• Mikaela Naylon Give Kids a Chance Act Federal legislative advocacy initiative championed by Kids v Cancer that was signed into law, expanding FDA authority over pediatric cancer drug development and reauthorizing the Priority Review Voucher Program.
• Priority Review Voucher Advocacy Advocacy for the Rare Pediatric Disease Priority Review Voucher Program, which incentivizes drug development for pediatric cancers. Program reauthorized through FY2029.
• DRAFT AI Tool to Find Therapies A draft AI-powered tool to help families identify possible drug therapies based on a child's genomic alterations. Available via the Kids v Cancer website.

Quantifiable outcome

• Mikaela Naylon Give Kids a Chance Act signed into law on February 3, 2026
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Mystic Force FoundationcoreStrategic or Co-development Partner · 3 February 2026Both organizations collaborate on annual Capitol Hill advocacy efforts to push for increased federal funding for childhood cancer research. Mystic Force Foundation has conducted advocacy for 13 consecutive years.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• St. Baldrick's Foundation: St. Baldrick's Foundation is the largest volunteer-powered charity funding pediatric cancer research, with parallel mission focus on childhood cancer research funding and federal advocacy. Both organizations mobilize grassroots communities to drive pediatric oncology outcomes and lobby for federal research dollars.
• Alex's Lemonade Stand Foundation: Alex's Lemonade Stand Foundation funds pediatric cancer research, supports families, and advocates for policy change affecting childhood cancer treatment access. It shares Kids v Cancer's combined research-funding and patient-navigation orientation and its donor-supported nonprofit structure.
• National Pediatric Cancer Foundation: The National Pediatric Cancer Foundation is dedicated to funding pediatric cancer research and reducing childhood cancer mortality, with a research-collaboration and advocacy model that overlaps with Kids v Cancer's policy and program agenda.
• CureSearch for Children's Cancer: CureSearch funds children's cancer research and advocates for federal policy to accelerate cures, with a similar combined funding-plus-advocacy operating model focused on pediatric oncology.
• Rally Foundation for Childhood Cancer Research: Rally Foundation raises funds for childhood cancer research and advocates for policy changes affecting young cancer patients, sharing Kids v Cancer's nonprofit, donor-driven approach to pediatric oncology research and federal advocacy.

Broad incumbents

• American Cancer Society: The American Cancer Society is the largest broad-based cancer nonprofit, funding research, influencing federal policy, and supporting patients across all cancer types including pediatric. It is a broader incumbent that competes for federal advocacy influence and donor dollars.
• American Association for Cancer Research (AACR): AACR is the premier professional cancer research organization and a formal Kids v Cancer partner. It shapes federal research funding priorities and policy across all cancer types, including pediatric, making it a broad incumbent that influences the same federal ecosystem Kids v Cancer targets.

Emerging players

• Coalition Against Childhood Cancer (CAC2): CAC2 is a collaborative network of pediatric cancer organizations that coordinates advocacy, research funding, and member organization initiatives. It is comparable because it operates in the same pediatric cancer advocacy space, often leveraging member organizations like Kids v Cancer to drive policy outcomes.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/KIDSvCANCER
• Facebookfacebook.com/kidsvcancer
• LinkedInlinkedin.com/company/kids-v-cancer

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kids v Cancer